Disclosures for "Dopamine Transporter Binding Abnormalities Are Associated with Self-injurious Behavior in Autism Spectrum Disorder"
-
Dr. Beversdorf has received personal compensation in the range of $0-$499 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Human Biosciences. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. Dr. Beversdorf has received personal compensation in the range of $0-$499 for serving as a Consultant for Stalicla. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scioto. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from Department of Defense. The institution of an immediate family member of Dr. Beversdorf has received research support from BionexusKC. Dr. Beversdorf has received personal compensation in the range of $10,000-$49,999 for serving as a Case Consultant with Best Doctors.
-
Mrs. Appling has nothing to disclose.
-
Mr. Prendergast has nothing to disclose.
-
Mrs. Nuraini has nothing to disclose.
-
Mr. Gonzalez has nothing to disclose.
-
Ms. Gunn has nothing to disclose.
-
Dr. Singh has nothing to disclose.